Improving Antibiotic Use to Treat Gonorrhea

CDC works to improve antibiotic use in community settings. This work helps to combat antibiotic resistance and protect patients from infectious diseases like gonorrhea.

The text below is available in a printable factsheet with graphics pdf icon[PDF – 1 page].

Factsheet: Improving Antibiotic Use to Treat Gonorrhea

Improving Antibiotic Use to Treat Gonorrhea

CDC is providing critical support to combat antibiotic-resistant bacteria by updating treatment guidelines.

Provide Guidance

CDC develops and updates the national treatment guidelines for gonorrhea to delay the emergence of drug-resistant gonorrhea.


CDC’s AR Lab Network gathers data about antibiotic-resistant gonorrhea from the Gonococcal Isolate Surveillance Project (GISP) to analyze trends in resistance. CDC uses this data to determine national treatment guidelines.


CDC funds the National Network of Sexually Transmitted Disease (STD) Clinical Prevention Training Centers (NNPTC) to educate clinicians who serve communities disproportionately impacted by or at risk for STDs. Webinars and courses reflect current gonorrhea treatment guidelines, and Clinical Consultation Services are available for clinicians who need additional guidance.


CDC monitors a representative sample of reported gonorrhea cases from the STD Surveillance Network (SSuN) to ensure that individuals are receiving the right drug at the right dose and duration to treat gonorrhea, based on CDC treatment guidelines.

Data Drives CDC Guidelines

  • GISP data drives CDC’s gonorrhea treatment guidelines.
  • STD Clinical Prevention Training Centers keep clinicians updated on current gonorrhea treatment guidelines.
  • SSuN data lets CDC know if providers are following the latest treatment guidelines.
Learn more

Visit the following CDC websites for more information: